Home
>
National Drug Code (NDC)
>
Pioglitazone HCL and Metformin HCL
Pioglitazone HCL and Metformin HCL - 13668-281-05 - (Pioglitazone HCL and Metformin HCL)
Drug Information of Pioglitazone HCL and Metformin HCL
| Product NDC: | 13668-281 |
| Proprietary Name: | Pioglitazone HCL and Metformin HCL |
| Non Proprietary Name: | Pioglitazone HCL and Metformin HCL |
| Active Ingredient(s): | 850; 15 mg/1; mg/1 & nbsp; Pioglitazone HCL and Metformin HCL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pioglitazone HCL and Metformin HCL
| Product NDC: | 13668-281 |
| Labeler Name: | Torrent Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202001 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130213 |
Package Information of Pioglitazone HCL and Metformin HCL
| Package NDC: | 13668-281-05 |
| Package Description: | 500 TABLET in 1 BOTTLE (13668-281-05) |
NDC Information of Pioglitazone HCL and Metformin HCL
| NDC Code | 13668-281-05 |
| Proprietary Name | Pioglitazone HCL and Metformin HCL |
| Package Description | 500 TABLET in 1 BOTTLE (13668-281-05) |
| Product NDC | 13668-281 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pioglitazone HCL and Metformin HCL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130213 |
| Marketing Category Name | ANDA |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 850; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
